We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 30. | After market close (AMC) | $-0.43 | — | — | $5.75M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.64 | — | — | $3.37M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-2.18 | — | — | $6.37M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-1.49 | — | — | $4.12M | Reported |
Consensus PT $24.1 · 5 analysts
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 12. | Amerx | — | Initiate coverage | — → Hold | — | Amerx: Hold |
| 2025. 12. 05. | Canaccord Genuity | — | Maintain | Buy → Buy | — | Canaccord Genuity: Buy |
| 2025. 08. 01. | Morgan Stanley | — | Maintain | Equal-Weight → Equal-Weight | — | Morgan Stanley: Equal-Weight |
| 2025. 07. 16. | Oppenheimer | — | Maintain | Outperform → Outperform | — | Oppenheimer: Outperform |
| 2025. 06. 18. | Roth Capital | — | Maintain | Buy → Buy | — | Roth Capital: Buy |
| 2025. 05. 16. | Oppenheimer | — | Maintain | Outperform → Outperform | — | Oppenheimer: Outperform |